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Abstract-The general principles governing the therapeutical removal of radiometals by 
chelating agents are outlined. Experimental data are presented demonstrating the dependence 
of chelate effectiveness on the number and the nature of ligand atoms as well ason themolecular 
configuration of the ligand. Implications derived from experimental data and from the multi- 
compartmental natureof a body Organ for working out an ~ptimaldosa~eschedulearediscussed. 
BEFORE we enter into the discussion of problems 
and experimental data concerning the thera- 
peutic removal of internally deposited trans- 
uranic elements, I would like briefiy to outline 
the principles governing this field and to show 
the direction in which it is developing. Although 
the corroborative experimental findings that I 
will quote do not deal directly with plutonium, 
the conclusions which can be drawn from them, 
particularly if lanthanides are involved, should 
be, to a certain extent, applicable and valid for 
the transuranic elements. The circumstance 
that all Papers which will be presented in this 
session are confined to the action of chelating 
compounds is not fortuitous. Rather, it is the 
consequence of the important Progress made 
quite recently in this tfirection, whereas all other 
approaches remain without any essential results. 
The experimental research on chelating agents 
a t  present pursues two main goals: first, the 
development of highly effective chelating com- 
pounds; and second, the elaboration of an 
optimal therapeutic regime for a given chelator 
which will guarantee a maximal radiometal 
mobilization and simultaneously avoid harmful 
side effects from the toxic action of the chelator. 
The factors relevant to the therapeutical 
effectiveness of chelating agents have been re- 
viewed comprehen~ively(~-~) and there is no need 
to repeat again the underlying ideas. I t  may be 
useful only to recall that the effectiveness of a 
chelator is related, among other factors, to the 
ratio of the chelate stability constant for the 
radiometal to the stability constant for calcium, 
an ion Lvhich markedly impairs the chelate 
effectiveness by competition. Generally speak- 
ins, this ratio can be infiuenced by varying the 
number of the electron-donor atoms, the nature 
of the donor groups and, finally, the molecular 
configuration of the ligand. 
In regard to the number of ligand atoms, a 
pronounced polydentate nature of the ligand 
can give rise to a marked increase in chelate 
stability. As a rule, this increase will be more 
pronounced the higher the coordination number 
of the meta1 ion involved. In keeping with this 
argument, we find for higher-dentate poly- 
aminopolycarboxylic acids a marked superiority 
in mobilizing radiocerium, radioyttri~m,(4?~) 
and thorium,(6) i.e., metals for which a maximal 
coordination number of 8 is likely(718) (Fig. 1). 
The stability constants for calcium, possessing 6 
coordination sites only, are almost identical in 
the case of EDTA (ethylenediaminetetraacetic 
acid), DTPA (diethylenetriaminepentaacetic 
acid), and (very probably) TTHA (triethylene- 
tetraaminehexaacetic acid). Somewhat un- 
expected is the observation that TTHA affects 
the deposition of radiocerium and radioyttrium 
in the liver to a lesser degree than DTPA. The 
reasons for this discrepancy are not yet fully 
understood. Because the higher homologue of 
DTPA, 12-dentate TPHA (tetraethylenepenta- 
amineheptaacetic acid), shows a relatively poor 
mobilization ability, we may conclude that the 
"polydentate principle" cannot be applied 
726 THERAPEUTIC REMOVAL OF INTERNALLY DEPOSITED RADIONUCLIDES 
lgand 
E0 TA 
DTPA 
TTHA 
TPHA 
number o f  
donor groups 
6 
B 
10 
12 
number of donor groups 
FIG. l.(4-6) Effect of EDTA, DTPA, TTHA, 
and TPHA on the retention of radiometals by 
organs of the rat. The calcium chelates 
(250 ,~iM/rat) were administered a few minutes 
post-injection (early treatment) or on the third 
day (delayed treatment) . 
indiscriminately. In  the case of TPHA, the 
formation of less stable bimetallic chelate species 
appears to be likely and to be responsible for 
the loss in effectiveness. As for plutonium, a 
superiority of TTHA over DTPA should be 
anticipated. 
Apart from the number of donor groups, the 
~ ( C H ~ C O O H ) ~  
(fHz)z ACHTA 
FIG. Effect of BADE and ACHTA (2- 
(B-aminoethoxy) cyclohexylaminetetraacetic 
acid) on the retention of Cei" by organs of the 
rat. The calcium chelates (250 ,uM/rat) were 
administered a few minutes post-injection. 
molecular configuration of the ligand may have 
a marked effect on its coordination tendencies. 
This might be eitherbyinfluencing the basicity of 
the donor atoms or by impairing (or making eas- 
ier)the metal-ligand orientation. However, our 
attempts(5,6) to obtain such specifically effective 
compounds for the mobilization of radiocerium 
or thorium have been unsuccessful so far. 
A derivative of 2 : 2'-bis[di(carboxymethyl)- 
aminoldiethyl ether (BADE), possessing a 
cyclohexyl ring instead of an ethylene group, 
gives rise to a higher excretion of radiocerium 
than BADE (Fig. 2). The similar substitution, 
however, in the DTPA molecule was not fol- 
lowed by a comparable increase in effectiveness. 
Furthermore, TTHA promotes a higher mobili- 
zation of radioceriurn and thorium than a 
C H ~ C H ~ N ( C H ~ C O O H ) ,  
/ 
N-CHzCOOH 
($2)2 
N-CHäCOOH 
'CH~CH,-N(CH~COOH), 
/ 
C H ~ C ~ N ( C H ~ C O O H ) ,  
N - c H ~ c ~ N ( C H , - C O O H ~  
\ CH,-CH~N(CH,-COOH)~ 
FIG. 3.(S,6) Effect of TTHA and TAAHA 
(tri-(2-aminoethy1)aminehexaacetic acid) on 
the retention of Th2* and Ceiaa by organs of 
the rat. The calcium chelates (250 /iM/rat) 
were administered a few minutes post-injection. 
related compound, although both agents have 
the Same number and kind of coordination sites 
(Fig. 3). 
Several heavy metals, such as lead, mercury, 
or polonium, prefer sulphur or nitrogen as a 
coordination Partner over oxygen while calcium 
behaves in the opposite fashion. I n  conformity 
with the higher stability constant ratios, we find 
that particular sulphur-containing polyamino 
acids (e.g., 2-mercaptoethyliminodiacetic acid 
and cystaminetetraacetic acid) reduce the radio- 
lead content of the kidneys and other organs to a 
much larger extent than do ordinary polyamino 
acids or structurally different SH-compounds 
with fewer donor g r o ~ p s . ( ~ )  As expected for the 
rare earths, the sulphur compounds do not show 
A. CATSCH 72 7 
any advantage;(l0P) this should obtain for plu- 
tonium also, considering the similar coordina- 
tion behaviour of lanthanides and actinides. 
The effectiveness of the chelating agents is 
greatly reduced with delayed treatment (Fig. I), 
and the difference between DTPA and TTHA 
disappears. The Same observations was re- 
ported quite recently forDTPAandBADE.(12-14) 
Although DTPA is superior to BADE if ad- 
ministered early, the amount of plutonium, 
radiocerium. and radiovttrium that can be 
removed by both compounds with delayed treat- 
ment is almost identical. This may occur be- 
cause as time passes, a major fraction of the 
radiometal deposited in the tissues is withdrawn 
from equilibrium and becomes unavailable to 
the chelators. The remaining and only loosely 
bound fraction could then be mobilized even by 
relatively weak chelators. Possible differences in 
the metabolic behaviour of different chelating 
agents, caused by structural dissimilarities or 
differences of the charges of the chelate ions, 
may also be taken intoaccount. The practical 
implication is obvious. More experimental 
investigation is needed with as many different 
compounds as possible. 
The main reasons for the more or less pro- 
nounced dependence of effectiveness on the 
time of chelate administration are the progres- 
sive transfer of the radiometal into biological 
compartments that bind it more tightly and/or 
the formation of so-called inert or sluggish 
chelates with endogeneous constituents. As has 
been pointed out by SCHWARZENBACH,('~) these 
two Parameters (i.e., the chelate stability con- 
stant and the constant of the velocity by which 
the association and dissociation of a chelate 
proceeds) are not necessarily correlated. 
T o  corroborate the possible importance of 
sluggish exchange reactions by an experimental 
result, I would like to mention an  observation 
we have made in the Course of our experiments 
with radioruthenium now under wav.(16) To  
obtain the maximum mobilization effect, we 
injected radioruthenium simultaneously with 
different chelating agents (Table 1). Among 
the compounds so far tested (polyamines, 
mercaptanes, and polyaminopolycarboxylic 
acids), the highest reduction of deposition was 
observed for radioruthenium chelated by 1 : 2- 
bis[2-di(carboxymethy1) aminoethylthio] ethane 
Table 1. Retention of Ru106 by Organs of the rat after an 
intravenous injection of  different Ru'06 chelates 
Per cent of control 
Chelate 
Blood P\.luscIes Liver Kidneys Skeleton 
'I'rien* 16 13 51 44 23 
Penten* 94 119 93 94 101 
DMPS* 44 32 36 158 36 
DMPA* 14 14 28 270 61 
EDTA 104 110 81 8 1 96 
DTPA 10 19 13 19 27 
BAEE* 89 I1 1 86 89 I03 
BATE 2.0 1.8 4.7 9.5 64 
* trien = triethylenetetraamine; penten = tetraki- 
(P-aminoethy1)-ethylenediamine; DMPS = 2,3- 
dimercaptopropanolsulphonic acid-(1) ; DMPA = 
2,3-dimercaptopropionic acid; BAEE = I : 2-bis- 
[di(carboxymethyl)aminoethoxy]ethane. 
(BATE), a compound that proved rather in- 
effective for all other radiometals previously 
tested. The effectiveness of BATE and of all 
other chelators quoted in Table 1 was almost 
completely abolished if they were administered 
shortly-even 1 min-after the injection of 
radioruthenium. This negative result is the 
more unexpected as radioruthenium is cleared 
from the blood rather slowly. By means of 
electrophoretic studies (Fig. 4), we have found 
that the stability of the Ru-BATE chelate is 
decisively higher than the binding of ruthenium 
by the serum proteins. When radioruthenium 
was added to a solution of BATE in serum, the 
fraction bound by the albumin and globulins 
remained negligible and the bulk of the activity 
migrated together with BATE. If, however, 
BATE was added to a solution of radioruthen- 
ium in serum, the binding ratio reversed, even if 
the solution was incubated for several days. 
These findings led us to the conclusion that the 
ruthenium-protein complex represents a typical 
inert chelate and that the formation of pre- 
dominantly covalent bindings is probably the 
responsible factor. 
In  this context, may I mention also a similar 
observation concerning the mobilization by 
DTPA of radiocerium from an intramuscular 
depot (Table 2). I n  the case of carrier-free 
radiocerium, its absorption from the injection 
site and excretion from the body can be largely 
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FIG. 4.(16) Electrophoretic behaviour of Ru106 
in serum containing BATE. Separation on 
cellulose acetate foils. 
enhanced by relatively few doses of DTPA, 
whereas both the absorption and the effective- 
ness of DTPA are significantly reduced with 2 
isotopically diluted radiocerium. I t  cari thus be 3 
e 
assumed that in the latter case a precipitate 
forms that is extremely slowly solubilized by the 
chelator. 
Let us now turn to questions concerning the 
effectiveness of multiple chelate doses and the 
elaboration of an optimal dosage schedule. time 
There are reasons to believe that the individual FIc. 5. Retention (log scale) ofa radiometal by 
terms of a multiexponential function, represent- an orgm composed of two parallel compart- 
ing the retention of a given radiometal by an  ments (a) ; hypothetical effect of multiple chel- 
organ, can be assigned to particular organ com- ate doses in the case of compartments arranged 
partments that presumably possess different in parallel (b) and in a series (C). 
barbdal bufhr p, 74 affinities toward the radiometal. Because the 
06mA cm-1 'thrs mobilizing capacity of a chelator depends 
BATE -C -1 
* 
essentially on the stability of the endogeneous 
radiometal complexes, it follows that its effective- 
ness is inversely proportional to the biological 
half-time and should decrease in the event of a 
multiexponential excretion function, indicating 
.s + the progressive increase of the "slow" com- 5 , s  * 
-2% ponent(s). For further consideration, the as- 
Table 2. Effect of d a i b  intraperitoneal doses of  CaNa3-DTPA (250 /cM on 3rd-7th day) on the 
retention of  intramuscularly injected Ce144 by rats 
(means and standard errors) 
.s $ 3  
I I 
Per Cent of dose 
Tissue Ce144 (17) Ce144 plus 1 mg Ce 
capillary space, the radiometal in the "fast" 
compartment can be removed fairly quickly by a 
chelator. Further administration only gives a 
relatively slight effect, due to the more stable 
binding of the radiometal by the "slow" com- 
* + partment (Fig. 5b). A second possibility is the 
1 
l o6~u  -vl
Control DTPA Control DTPA 
sumptions made about the arrangement of the 
compartments are essential. If we deal with 
so-called parallel compartments (Fig. 5a), all of 
them standing in direct exchange with the extra- 
Injected leg 17.5 + 1.2 8.2 & 0.3 83.4 & 3.2 73.7 1 4 . 8  
Opposite leg 2.6 & 0.1 1.4 1 0.04 < 0.1 < 0.1 
Liver 16.4 i 0.5 1.5 5 0.07 0.32 & 0.04 0.14 & 0.02 
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serial arrangement of the compartments-only 
one compartment communicating directly with 
the extracapillary space. If  the compartments 
are arranged in order of the increasing affinity 
toward the radiometal and the transfer of the 
radiometal within the series proceeds rather 
slotvly, a quite different effectiveness pattern 
results and the net amount of excreted radio- 
metal will be markedly higher (Fig. 5c). As to 
the retention of radiocerium by the liver, our 
experimental data(18) favour the assumption of 
at least two compartments arranged in parallel 
(the effects of several successive DTPA doses 
were not fully additive). Analyzing the data of 
SCHUBERT ef al.(l9) with plutonium (Fig. 6), we 
! l l l , , ! ! ! :  
skelefon 
days -, 
FIG. 6.(19) Removal of monomeric by 
multiple DTPA doses (500 mg/kg) from Organs 
of the mouse. 
come to the same concIusion. DTPA was given 
here in daily doses for 18 days and its effective- 
ness was relatively quickly exhausted. I t  is likely 
that the same net effect might have been ob- 
tained by a smaller number of doses. Further- 
more, one might be in doubt about the appropri- 
ateness of the dosage schedule used (i.e., the 
daily administration of DTPA). The action of 
a highly effective compound such as DTPA is 
sustained over several days.(12J3Js-"2) Con- 
sequently, tve must consider the possibility that 
successive and too narrotvly spaced doses are less 
effective than if each dose is given only after the 
complete cessation of the action of the preceding 
dose (Fig. 7). To elucidate this point, we car- 
ried out the follolving experiment. Rats injected 
Frc. 7. Hypothetical retention (log scale) of a 
radio metal as affected by two chelate doses. 
The second dose is given after different time 
intervals. 
with radiocerium were given three doses of 
DTPA ori the third, fourth and fifth day in the 
first group, and on the third, sixth and tenth day 
in the second. The foregoing assumption can be 
verified by referring to Table 3. Multiple che- 
late doses given within a short time lower the 
radiocerium content of the liver to only 2 1 per 
cent of the control value: the less narro\vlv 
spaced dosage gives a reduction to 16 per cent. 
This differente is statistically significant. On tlie 
other hand, the response of skeleton and kidneys 
to both dose schedules is almost identical. This 
is in keeping trith our earlier statement(l8) that 
the sustained action of DTPA is confined to the 
mobilization of radiocerium from the liver. We 
may therefore deduce from these findings that a 
pro;racted dose schedule is preferred-at least 
in dealing with liver-seeking radiometals- 
because it gives a higher mobilization and ought 
to be less harmful. 
I n  conclusion, I might deal briefly with the 
effect of esterified polyaminoacids. Some 
time ago we reported(3,g.") that tlie cster-lac- 
tones enhance the mobilization of radiocerium, 
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Table 3. Retention of Cel*Qy organs of the rat as affected by multiple CaNa3-DTPA doses 
(250 ,uM/rat) given on the third, fourth andJifth day (experiment A) or on the third, sixth 
und tenth day (experiment B) .  All animals were sacnficed 14 days after injection of Ce1**. 
Ten animals @er group. 
(Means and Standard errors) 
- 
Per cent of dose D 
Organ 
Experiment A Experiment B ( A  vs. B) Con trol 
Liver 12.4 0.88 2.65 & 0.16 1.94 + 0.21 0.02-0.01 
Kidneys 0.50 i 0.020 0.36 & 0.019 0.35 5 0.027 0.8 -0.7 
Skeleton 24.8 0.65 16.5 + 0.46 17.6 1 0.48 0.2 -0.1 
radioyttrium, and lead from the parenchyma- 
tous organs to a higher degree than the ordinary 
calcium chelates of the underlying polyamino 
acids. I t  was thought that the higher effect of 
the ester is brought about by its ability to per- 
meate cellular membranes. Since then we have 
tested a new compound, the ester-lactone of 
BADE, and are able to confirm our earlier find- 
ings. The  effect of this compound, however, 
remai~is low as compared to DTPA. Final 
conclusions about the value of this approach can 
be drawn onlv wlien the ester of DTPA becornes 
available. Nevertheless, considering the relative- 
ly high effectiveness of BADE in removing 
a screening test on the effect of the 
BADE-ester in this case might be justified. 
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Retention in the Skeleton of Radiostrontium 
as influenced by Tetracycline 
SEVEBAL recent investigations have directed attention 
to the influence of tetracycline on the metabolic behaviour 
of radiostrontium. The results, however, are ambiguous. 
I n  contrast to Nakatsuka et al.1, who were not able to 
observe any significant effect, it was claimed by Ogawa 
et a1.2 that tetracycline administered immediately after 
radiostrontiurn injeetion prevents its skeletal deposition 
and enhanees its urinary excretion. This effect was thought 
to be due to the ehelating properties of the compound. 
Positive results were also obtained by Richards et aL3. 
Repeated daily doses of tetracycline-given 4 days prior 
until 24 days after the administration of radiostrontium- 
did not affect the initial deposition of radiostrontium, biit 
rather accelerated its elimination from the bone. The 
troatment schedulo used by the foregoing authors, how- 
ever, does not pormit deciding whether the pre-treatmont, 
or post-troatment, or both, wero responsible for the effoct. 
In  order to  elucidate this question, albino rats and 
miee, injected with tracer amoiints of carrier-free 8sSrN03, 
were treated with tetracycline hydrochloride (by courtesy 
of Farbenfabriken Bayer ,4G, Leverlcusen) in different 
ways. Tho dosago of totracyclino was the saino as that 
used by Richards et al.; it proved, howover, to be tosic, 
and several animals diod in the courso of tho esperiment. 
Both femurs were ashed a t  600' C and their activity 
assaysd by use of a sodium iodide (Tl)-scintillation 
crystal. The strontium-85 eontent of the whole slreleton 
was assumed to equal the ten-fold aetivity of botli femurs. 
The results (Table 1) show that neither post-treatmerit 
nor tho simultaneous administration of tetracycline givcs 
rise to a reduced skeletal retention of strontium-85. On 
tho contrary, one experimental series appears to indicato 
that the eliminntion of strontium-85 from the bone is 
inhibited. A sinnificantlv rcduced deposition was achieved 
by tetracyclinÖonly if given prior io injection of stron- 
tium-85. 
Table 1. STRoNTInar-85 CONTENT OB TIIE SKELETON ( EAN AVERAGE .L $.E.) 
No. of Average 
Treatment rat? (R) or body-wt. Day of s5Sr-dose I' (nig tetracycliiie/kg) mice (M) (g) dentli (per cent) 
Control 
Simultaneously 
Control 
4 days prior 
contro1 
10 days after * 
Control 
5 days prior 
10 days after* 
* Treatment was started 24 h after injection of strontium-85. 
These findings make it unlikely that the effectiveness of 
tetracycIine can be attributed to the chelation of radio- 
Strontium. On the other hand, taking into account the 
pronounced affiity of tetracyciine to bone tissue4-7 
(which is thought to be due to the formation of cdcium 
chelates in aitu'), we may tentatively assume that this 
reaction leads to an impairment of the mechanism(s) 
responsible for the retention of radiostrontium by bone. 
As to the mode of action, fhal conclusions can be dmwn 
only if more detailed investigations on the effectiveness 
of different tetracyclines, doso dependence, time and 
duration of treatment, are made available. Such experi- 
ments aro now under way and will be published elsewhere. 
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